Beta Bionics (BBNX) Gross Margin (2024 - 2026)

Beta Bionics has disclosed Gross Margin across 3 years of filings, most recently posting 59.04% for Q2 2026.

• In Q2 2026, Gross Margin rose 524.0% year-over-year to 59.04%; the TTM figure through Jun 2026 stood at 58.31% (up 438.0% YoY), while the FY2025 annual figure was 55.4%, up 29.0% from the prior year.
• Gross Margin came in at 59.04% for Q2 2026 at Beta Bionics, down from 59.5% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 59.5% in Q1 2026 to a low of 50.86% in Q1 2025.
• Average Gross Margin over 3 years is 55.76%, with a median of 55.58% recorded in 2025.
• Year-over-year, Gross Margin tumbled 482 bps in 2025 and jumped 864 bps in 2026.
• Over 3 years, Gross Margin stood at 57.19% in 2024, then climbed by 3 bps to 58.98% in 2025, then grew by 0 bps to 59.04% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 59.04% in Q2 2026, 59.5% in Q1 2026, and 58.98% in Q4 2025.